The Lyfebulb-Novo Nordisk Innovation Summit 2017 will recognise and empower international patient entrepreneurs with big ideas that disrupt the future of diabetes management.

Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives of people living with type 1 or type 2 diabetes. The Lyfebulb-Novo Nordisk Innovation Summit, which will take place between 6-8 November, will bring together 10 patient entrepreneurs with Lyfebulb founders, device researchers, engineers and leadership from Novo Nordisk and venture capitalists to facilitate discussion on how we can improve the lives of people living with diabetes. Contestants will engage in Q&A with the judging panel from around the world.

The top three patient entrepreneurs will receive monetary awards: There is a 25,000 USD winner of the 2017 Lyfebulb-Novo Nordisk Innovation Award, as well as the 15,000 USD runner-up and 10,000 USD third place winner.

Dates for Submissions: Between 7 June 2017 and 15 September 2017, a review of which will be made shortly thereafter, and a selection of ten finalists will be announced in the fall of 2017.

For further information and to apply, visit